Company Overview of BioDiem Ltd.
BioDiem Limited, a biopharmaceutical company, develops and commercializes vaccines and infectious disease therapies primarily in Australia and India. The company offers Nasovac-S, a seasonal influenza vaccine based on live attenuated influenza virus technology that is used for the production of seasonal and pandemic influenza vaccines. It is also developing SAVINE, a scrambled antigen vaccine technology for use in the design and customization of immune-stimulation proteins that are used in new vaccine design; and BDM-I, an antimicrobial technology for the treatment of fungal disease, and pneumocystosis and tuberculosis infection. The company is based in South Melbourne, Australia.
100 Albert Road
South Melbourne, VIC 3205
61 3 9692 7240
61 3 9077 9233
Key Executives for BioDiem Ltd.
BioDiem Ltd. Key Developments
Similar Private Companies By Industry
|4G Vaccines Pty Ltd.||Asia|
|Advent Pharmaceuticals Pty Ltd.||Asia|
|AFT Pharmaceuticals Pty Ltd||Asia|
|Anagen Pty Limited||Asia|
|Ascend Biopharmaceuticals Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact BioDiem Ltd., please visit www.biodiem.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.